Microdissection-Based Allelotyping: A Novel Technique to Determine the Temporal Sequence and Biological Aggressiveness of Colorectal Cancer

Pathologic staging in colorectal adenocarcinoma (CA) is based on the concept that the timing of metastatic tumor spread is directly related to the depth of the primary tumor invasion. To evaluate the temporal sequence of CA metastasis, we performed microdissection mutational profiling at multiple microscopic sites of primary and metastatic CA specimens. Twenty-one cases of CA were selected from fixed-tissue archives. Primary tumors were microdissected at the deepest point of invasion. Comparative mutational profiling for different genomic loci [1p36(CCM = cutaneous malignant melanoma], 3p26(OGGI = 8 oxoguanine DNA glycosylase), 5q23 (APC, MCC = mutated in colorectal cancer), 9p21(p16/CDKN2A = cyclin-dependent kinase 2A), 10q23(PTEN = phosphatase and tensin homolog [mutated in multiple advanced cancers 1]), 12p12(K-ras-2 point mutation), 17p13(TP53), 18q25(DCC= deleted in colorectal cancer) was carried out on each microdissected tissue target using microsatellite loss of heterozygosity determination or DNA sequencing. All primary and metastatic sites of CA manifested acquired mutational change in 18 to 91 per cent of the genomic markers. In 15/21 (71%) cases, metastatic sites lacked a specific allelic loss seen in the corresponding primary tumor, indicating that the metastasis occurred before maximal depth of primary invasion. This was further supported by discordant mutational profiles between primary and secondary tumors, requiring divergent clonal evolution. This is the first report describing the temporal sequence and significance of sequential mutational acquisition in clinical tissue specimens with potential implications for a new molecular pathology approach to classify human cancer.

[1]  J. Dreesen,et al.  Allelic dropout caused by allele-specific amplification failure in single-cell PCR of the cystic fibrosis ΔF508 deletion , 1996, Journal of Assisted Reproduction and Genetics.

[2]  P. Ray,et al.  Reduced allele dropout in single-cell analysis for preimplantation genetic diagnosis of cystic fibrosis , 1996, Journal of Assisted Reproduction and Genetics.

[3]  S. Finkelstein,et al.  Primary duodenal carcinoma showing divergent growth patterns as determined by microdissection-based mutational genotyping. , 2003, Archives of pathology & laboratory medicine.

[4]  S. Finkelstein,et al.  Microdissection‐based allelotyping discriminates de novo tumor from intrahepatic spread in hepatocellular carcinoma , 2003, Hepatology.

[5]  C. Compton.  Colorectal Carcinoma: Diagnostic, Prognostic, and Molecular Features , 2003, Modern Pathology.

[6]  S. Finkelstein,et al.  Genotypic analysis of primary and metastatic cutaneous melanoma. , 2003, Cancer genetics and cytogenetics.

[7]  J. Biegel,et al.  Risk assignment in childhood brain tumors: The emerging role of molecular and biologic classification , 2002, Current oncology reports.

[8]  I. Pollack,et al.  Expression of p53 and prognosis in children with malignant gliomas. , 2002, The New England journal of medicine.

[9]  S. Thiagalingam,et al.  Loss of heterozygosity as a predictor to map tumor suppressor genes in cancer: molecular basis of its occurrence , 2002, Current opinion in oncology.

[10]  S. Finkelstein,et al.  Distinguishing de novo second cancer formation from tumor recurrence: mutational fingerprinting by microdissection genotyping. , 2001, The Journal of molecular diagnostics : JMD.

[11]  T. Godfrey,et al.  Correlation between dysplasia and mutations of six tumor suppressor genes in Barrett's esophagus. , 2001, The Annals of thoracic surgery.

[12]  H. McLeod,et al.  Application of laser capture microdissection and proteomics in colon cancer , 2001, Molecular pathology : MP.

[13]  S. Finkelstein,et al.  Multiple genetic alterations involved in the tumorigenesis of human cholangiocarcinoma: a molecular genetic and clinicopathological study , 2001, Journal of Cancer Research and Clinical Oncology.

[14]  J. Rüschoff,et al.  Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma. , 2000, The American journal of pathology.

[15]  J. Taubenberger,et al.  Genetic Heterogeneity in Ductal Carcinoma of the Breast , 2000, Laboratory Investigation.

[16]  Carissa A. Sanchez,et al.  Evolution of neoplastic cell lineages in Barrett oesophagus , 1999, Nature Genetics.

[17]  S. Finkelstein,et al.  Bronchioloalveolar adenocarcinoma of lung: monoclonal origin for multifocal disease. , 1998, The American journal of surgical pathology.

[18]  I. Findlay.  Approaches for cystic fibrosis diagnosis. , 1997, Human reproduction.

[19]  J. Findlay,et al.  P-227. Regulation of follistatin production by rat granulosa cells in vitro , 1997 .

[20]  Cooper,et al.  Prediction of Biologic Aggressiveness in Colorectal Cancer by p53/K-ras-2 Topographic Genotyping. , 1996, Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology.

[21]  Z. F. Liu,et al.  Allelic loss of chromosome 18q and prognosis in colorectal cancer. , 1994, The New England journal of medicine.

[22]  G. Viale,et al.  Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas. , 1994, Journal of the National Cancer Institute.

[23]  G. Chenevix-Trench,et al.  Association of the SS genotype of the L-myc gene and loss of 18q sequences with a worse clinical prognosis in colorectal cancers. , 1994, Oncogene.

[24]  G. Taylor,et al.  Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. , 1993, Gastroenterology.

[25]  J. Benhattar,et al.  Stability of K-ras mutations throughout the natural history of human colorectal cancer. , 1992, European journal of cancer.

[26]  O. Delattre,et al.  Survival and acquired genetic alterations in colorectal cancer. , 1992, Gastroenterology.

[27]  A. Tanigami,et al.  Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. , 1990, Cancer research.